Glasgow scientists pioneer AI tech for epilepsy control
EuroWire, EDINBURGH: Scientists in Scotland have developed an artificial intelligence-powered headset capable of predicting epileptic seizures minutes…
Novo Nordisk’s amycretin achieves breakthrough obesity trial results
Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting…
Spravato becomes first FDA-approved standalone depression treatment
FDA approves Johnson & Johnson’s Spravato as a standalone therapy, marking a…